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and sustained a bladder injury during the operation.
The repaired fistula did not hold, and the patient has
since died without a further attempt having been made
to cure the fistula.
Bantu (3). One of these cases was cured but broke
down I month after her discharge from hospital-
probably owing to intercourse as she was admitted
having aborted incompletely 3 months after discharge.
In another patient the first attempt was unsuccessful.
It is a fistula which should be closed relatively easily.
She, however, has failed to report back. The last
patient has been referred to above; she has a cloaca
together with an osteitis of the pubic bone, and left
hospital with a colostomy and ileal bladder.
CONCLUSION
Since the appearance of a report of a William Meredith
Fletcher Shaw lecture delivered by Mahfouz,5 the full
text is awaited with interest. This great gynaecologist
has repaired 968 vesico-vaginal fistulae. His last 300
cases were all successful. Excellent results are reported
by Charlewood,1 LaverY,3 Miller6 and Moir.? In most
cases the operation is straightforward and therefore it
is unnecessary to resort to transplanting ureters into
the rectum unless the patient has been given a full
chance of having function restored to an organ which
in most instances can be made to function normally.
o stone should be left unturned in attempting to
cure vesico-vaginal fistulae. There are few patients
on this earth who are more relieved mentally and
physically than those suffering from this preventable
and distressing defect.
That these patients in our unit have done exceptionally well
is in no small measure due to the first-rate attention given to
them by the nursing staff, house surgeons and registrars.
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(e) abreactives, such as CO2 used in inhalation
therapy and acetylcholine used intravenously;
(I) the hallucinogens. of which lysergic acid is the
most commonly used;
(g) sympathetic inhibitors such as reserpine; and
(h) the anticholinesterase drugs, such as chlor-
promazine and the antihistamines.
This list could be further enlarged and its subdivisions
are by no means mutually exclusive as chlorpromazine
as well as being an anticholonesterase has a sympathi-
colytic effect, but it is given to remind one of the com-
plexity of the question of pharmacological control of
the psyche.




The pharmacological control of emotional disorders
and psychiatric conditions has become prominent in
recent years. Few workers would consider such control
in itself sufficient; indeed it is difficult to arrange matters,
even with the 'double blind control' in which neither
physician nor patient is aware of what tablet is being
given, so that suggestion is completely excluded, for
the mere giving of a placebo will make some impression
on the patient. In the small series described below
psychotherapy was given to each patient as was con-
sidered most fitting; no attempt has been made at
rigid scientific control but the venture has been ap-
proached as a clinical trial, with as open and unbiased a
mind as possible, against the background of fairly
extensive use of chlorpromazine in an analagous group
of patients seen in private practice.
The drugs commonly used as pharmacological aids
in the various disorders which are by general acceptance
termed 'functional' may be divided under several"
headings:
(a) The sedatives, which act largely on the cerebral
cortex, and of which barbiturates represent by far the
largest group;
(b) The stimulants, of which the amphetamine
group, caffeine and some phenyliso-propylamine deri-
vates such as Ritalin are representative;
(c) the hormones, such as thyroid, oestrogens,
androgens and various steroid derivatives;
(d) relaxants of the dioxolane group, such as dime-
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Owing to its heterocyclic chain structure it differs
chemically from cWorpromazine. The two graphic
formulae are as follows:
Pacatal has a relatively fow toxicity and has been
given continuously to dogs for 2 months, without any
untoward effects, in doses of 10-20 mg. per Kg body-
weight, orally. It appears to have some depressant
effect on the parasympathetic nervous system since it
blocks the action of pilocarpine on salivary flow in
rabbits and inhibits secretions in rats. l Its mydriatic
activity is slight but it has a distinct drying effect on
the upper respiratory passages.2
On the sympathetic system Pacatal has a depressant
effect; it causes inhibition ofcontraction of the nictitating
membrane. The cartoid-sinus reflex and pressor re-
flexes were inhibited but noradrenaline was not blocked.
In normal individuals 50 mg. of Pacatal given intra-
venously was found to lower the blood sugar slightly.3
Pacatal, like cWorpromazine, potentiates the analgesic
properties of morphine and phenacetin and reduces the
reaction to pain by both a peripheral and central action.4
Pacatal has not the same effect as chlorpromazine on
the circulatory system, because it does not lower the
blood pressure or affect the pulse rate. 3
In estimating the qualities of any drug clinically, the
venue for the trial must be carefully chosen so as to
show up the qualities of the drug most advantageously
as well as define its limitations. It is obviously wrong
to estimate the effect of a drug solely suitable for the
sedation of mildly agitated persons by trying it only
against wildly maniacal psychotics; a negative finding will
be arrived at (that the drug is useless in mania) but no
positive affirmation can be made. The negative dis-
covery is of course of some value in defining the bound-
aries of future trials but it is not sufficient in itself.
In the following summary of a recent trial of Pacatal,
2 main groups of patients were used: (a) Ambulatory
persons who were going about their daily tasks but
who found certain difficulties such as tension, lassitude,
insomnia and depression, interrupting their usual
efficiency, and (b) patients who had been so severely
affected as to warrant nursing-home treatment. There
were no cases of the certifiable class. Amongst those
who were receiving nursing-home care a further division
could be made into those receiving some form of
electroconvulsive or electronarcotic therapy and those
who were not receiving this therapy.
Dosage. Pacatal was supplied in SO mg. tablets and
in ampoules of 50 mg. in 2 c.c. solution.
In most of the nursing-home group an initial deep
intramuscular injection of 75 mg. was given followed
by 100-200 mg. by mouth.
With ambulatory patients 50 mg. was given t.d.s.,
or if the problem was mainly one of poor sleep an
initial 100 mg. of the drug was given t hour before
retiring. In a few cases the dosage was raised to 100 mg.
t.d.s. With those who were treated in bed an initial
dose of 75-100 mg. was given intramuscularly.
It was found that by diluting this dose with sterile
water to 10 c.c. the pain of the injection was reduced.
At first deep muscular injections were not given and
most of the patients complained of severe pain; local
anaesthetics such as 2 % procaine were not found to
be satisfactory in overcoming this pain, and when the
anaesthetic effect wore off the patient continued to
complain of pain for a further 24-48 hours. Later the
injections were given deeply into the buttock muscle
and this was found to be much less painful. Hyal-
uronidase was given with some of the intramuscular
injections but apart from appearing to hasten the
calming effect of Pacatal it did not seem to have any
other effect and the injection site remained tender.
In the very excited, agitated and hypomanic case
the dosage required was very variable, and although
800 mg. a day in divided doses was usually sufficient
to induce calm sleep, there were case where this dosage
was quite inadequate.
Finally, except in the ambulant cases, Pacatal alone
was not usually sufficient to quiet the patient and the
drug had to be used in combination with a barbiturate.
A very satisfactory method of inducing therapeutic
sleep for a week or 10 days was found by combining
200 mg. of Pacatal with 400 mg. of oludar (Roche),
i.e. 2 tablets of the latter drug every 6 hours. As some
patients object to taking large numbers of tablets the
Pacatal and oludar were often cru hed and given
together as a powder to be swallowed with water.
SIDE-EFFECTS
Dryness of the mouth and a loss of taste was a frequent
complaint of patients taking Pacatal. A few com-
plained of blurring of vision and in those having high
dosages dizziness and actual ataxia occurred. Many
patients remarked on their vivid dreams while talOng
the drug, an effect which is shared with chlorpromazine.
There were no cases of jaundice or blood dyscrasia.
Of the 53 patients under treatment with Pacatal,
3 developed nausea and 1 vomited after being given
the drug. Anorexia might be a side-effect in about a
quarter of the patients, but this was difficult to estimate
because in many patients anorexia was part of the
symptom-complex which led them to consult their
doctors.
Despite the experimental evidence that Pacatal had
little anticonvulsant effect,! clinically in giving electro-
convulsive treatment to patients it was found to have
a very marked anticonvulsant effect. This is a drawback
in electroconvulsion therapy since, if a convulsion is
not produced, the patient is often confused for a con-
siderable time after the treatment. It must, however,
be remembered that part of this anticonvulsant effect
is due to the potentiating effect of Pacatal on barbi-
turates and oludar. It was noticed that intramuscular
Pacatal alone had no adverse effect on electrocoma
treatment, where a convulsion is not aimed at, and
indeed it seemed to help considerably in this treatment,
for patients who tended to wake up 2-3 minutes after
the commencement of treatment were found to take
the full 10-15 minutes of passage of electric current
without waking after administration of the drug in
its usual daily dosage.
CASE RECORDS
In starting trials with a new drug there are bound to
be failures for two main reasons, firstly because the
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The patients who were depressed without a great deal
of tension were those who did least satisfactorily on
Pacatal. As with chlorpromazine the best results were
those who were agitated, restless, sleepless and tense.
A few illustrative case notes may be of help in esti-
mating the effects of Pacatal:
medicament is used on unsuitable cases, and secondly
because inadequate dosage or too high a dosage is
used. Only by trial and error 'can an estimate be arrived
at, and the over-all clinical impression at the end of
the trial is probably of more importance than any
study of statistical effects. The reader is therefore
referred to the concluding remarks of this article before
judging from the following figures.
Furthermore Pacatal alone in a few of the more
severely affected cases was not sufficient, but by its
potentiating effects it was most useful in cutting down
the amount of barbiturates or other drugs' given.
The following tabulation shows the satisfactory as
compared wiht the unsatisfactory responses. The
latter group include those in which the drug was aban-
doned either because it was ineffective or because of
the resulting anorexia or nausea or dryness of the
mouth.
Case I. H.W., a journalist 48 years of age, had for the last
3 years found himself becoming increasingly tense and sleepless.
He had had a considerable amount ofdomestic anxiety and his work
was unsatisfactory and frustrating. He had a typical tension-
reaction to all this background of real worry and he found he
could not concentrate or settle to anything and his sleep was
broken and unrefreshing. He was a man of high intelligence and
initiative and had no previous breakdown; he still did his work
but he felt as if 'something would happen' if he did not achieve
sleep and relaxation; amphetamine, various sedatives, a sea-trip
and advice from a number of physicians had all been without
avail.
After a preliminary psychotherapeutic interview and survey
he was put on to Pacatal, 50 mg. r.d.s., and when seen a week
later he was much better. He felt less tense and, although h~ took
nothing else to induce sleep at night, he slept well. He has been
seen at weekly intervals for 6 weeks and has remained well. His
impression is that Pacatal does not make him feel lethargic in
any way during the day but helps him to sleep at night by giving
him what he calls a 'more relaxed platform' to start off the night.
Case 2. A.P., a physician 49 years of age. For 7 years he had
been taking drugs-omnopon, pethidine and large amounts of
barbiturates. He was desperately trying to stop the drugs but
when seen was in a state of great depression and agitation. He
would pace up and down his room wringing his hands, clutching
his head and appealing for help from his inner restless torment.
He was taken into a nursing home and given 75 mg. of Pacatal
i.m. and put on 200 mg. t.ds. He immediately became quieter
14 8
Case 4. P.B. aged 40, a chemist by trade, had been undergoing
a considerable amount of stre;;s relating to a business partnership
and building undertakings. He had always been a very quiet
man, perfectly self-contained, but rather suspicious. For a week
before being first seen he had been restless, talkative, and mildly
elated. The day before he was seen his elation and activity in-
creased, and when seen he was in a typical hypomaniac state
with a great pressure of talk, llights of ideas, and moods which
swung from an all-embracing euphoria to swift and angry aggres-
siveness. He knew a good deal about the effect of drugs and
refused to take barbiturates in any form 'because of the danger
of suicide' and refused to have chlorpromazine 'because it causes
jaundice'. He was eventual!y persuaded to take Pacatal, 200 mg.,
and Noludar, 400 mg., crushed up together and was kept on this
dosage 3 or 4 times daily for ID days, during which time he had
electroconvulsive therapy. He made a full and surprisingly un-
eventful recovery except for the 4th day of treatment, when he
refused all drugs by mouth and became very elated and aggressive
and had to be given 100 mg. of Pacatal by injection.
Comment. Both these patients were intelligent men
trained, in different ways, to observe reactions. Both
were quite certam that Pacatal was effective where
other sedatives of the barbiturate, bromide and hyoscine
groups had been ineffectual. In the doctor patient
Pacatal failed to relieve the supervening intensely felt
feeling of restlessness in the limbs although it calmed
him inwardly in a satisfactory manner. In the first
case, by dissolving the bands of his tension, it allowed
the patient to continue at his work with better con-
centration and more zest than previously, and in the
second case it produced calm sleep with quite small
doses of paraldehyde in a man accustomed to taking
big doses of various drugs.
Case 3. L.M., a European housewife aged 35 years, with occi-
pital headache, frontal and periorbital pain, usually on the right
side but sometimes on both sides. These headaches had been
present for some years and were often precipitated by fatigue or
emotional upset, but latterly had tended to become more'and more
frequent and to last up to a week at a time. The usual remedies
for migraine had failed to help them and they were undoubtedly of
that class of headache called 'muscle-contraction headache' by
Tunis and Wolff. 5 On Pacatal, 50 mg. t.d.s. and 100 mg. at the
very onset of a headache, she was much improved. Although she
usually lay down for an hour or so after the 100 mg. dose she
would avert the headache, which previously would have incapaci-
tated her for at least a day.
Commenl. The muscle-contraction type of headache
is a common cause of distress and partial incapacitation
amongst people of all classes, but particularly in the
housewife in her thirties and forties with the usual
press of duties and responsibilities and the stress of
modern living. Psychotherapy certainly plays a major
part in the resolution of this kind of headache, together
with rearrangement of the living-pattern into a less
stressful form, but what the patient usually craves for
is something to take which will give an immediate
relief from symptoms. Pacatal in the dosage given
above, has been of great help in this kind of case.
and less agitated and slept for 14-18 hours a day with the aid of
paraldehyde, ID ml. by mouth twice daily.
A week later he began to complain of a restlessness in his legs,
the 'jittery legs' of Ekbom, which did not respond to increased
doses of Pacatal or chlorpromazine, but which re;;ponded tem-
porarily to reserpine.
Comment. This case raised some extraneous diffi-
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turates or cWorpromazine. Nevertheless Pacatal
proved itself an excellent substitute and indeed, along
with Noludar, it is difficult to see how the case could
have been better controlled. It should be made clear
that the Pacatal merely facilitated nursing and the
giving of the electroconvulsive therapy-it was the
latter which improved his hypomania-but without
Pacatal the management of the case and the rapid
recovery could not have been achieved.
CO 'CLUSIONS
Pacatal compares favourably with chlorpromazine in
the control of a group of cases with emotional dis-
orders, tension states, and muscle-contraction head-
aches. It is not in itself a nostrum but it does help the
physician in the management of the patient and it
helps the patient by lessening ~s inner tension. Nearly
all those who took Pacatal said they felt calmer and
slept more readily. The side-effects as compared with
those of cWorpromazine are few-no rashes, no jaun-
dice, no blood dyscrasia, no marked alteration of
blood pressure or pulse rate. It did, however, produce a
dryness of the mouth which was unpleasant in some
cases; blurred vision, anorexia and, in big doses, ataxia
were also produced, but it should be noted that the
bigger doses were usually employed only in the most
severely agitated cases and the side-effects were mild
compared with the increased control of agitation and
tension.
As with cWorpromazine, the dosage required for
individual patients may vary from 100 mg. in one to
800 mg. in another, though they may be clinically
comparable. In our experience, Pacatal proved some-
what more painful than chlorpromazine on injection,
but by means of dilution with water and deep injection
this can be ameliorated.
In using Pacatal one must remember its potentiating
effects, which are like those of chlorpromazine, on
hypnotics and analgesics. In electroconvulsion therapy
Pacatal seems to have an anticonvulsant effect which
may make the treatment more difficult, but in electric-
coma treatment it helps, probably by potentiating the
effect of the introductory intravenous thiopentone, in
keeping the patient asleep while the current is being
passed.
SUMMARY
Pacatal, a phenothiazine derivative, is structurally
related to cWorpromazine but differs in ItS heterocyclic
side-chain structure. Indications for its use are similar
to tpose for chlorpromazine but it has less side-effects.
There is a very definite place for the use of Pacatal
and some indications for its use are discussed.
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The first part of the above heading needs no explanation, extension
or argument for any medical people whose work brings them into
direct contact with this disease, especially as it occurs amongst
the Bantu. But even for some of them, and certainly for the
many medical practitioners in the multitude of diverse specialties
and occupations contained in Medicine today who are not im-
mediately concerned with the ravages of this particular disease,
the second part of the heading certainly calls for some sort of
explanation and justification. It is my purpose to endeavour to
supply both: not because I wish to attack SA ITA (the South
African National Tuberculosis Association) as such, but because
I feel strongly that the presence of SANTA in our midst is (un-
wittingly) blinding the eyes of Government and public alike to
the vastness of this whole problem. And when I say Government
I am not referring specially to the present Government, but to
any Government. There is nothing political in this, because this
is a matter altogether beyond party-politics: and there is nothing
personal in it, except that, as a person who has been engaged for
nearly 30 years in working with and for sick Bantu, I have some
small claim to know what I am writing about.
The immensity of the problem of tuberculosis as it occurs in
the Bantu has been ever before me for many years; and I have
tried without success during the past few years to get, through
the Union Department of Health, an adequate grant to enable
us to build a separate tuberculosis hospital here to accommodate
the ever-increasing number of patients suffering from open pul-
monary tuberculosis who come seeking admission. But always
we have come up against the stone wall erected, unwittingly no
doubt, by SA TA in their provision of serrlement beds at a cost
not exceeding £150 per bed-a price at which it is impossible to
build and equip a hospital. In the end our Hospital Board decided
to drop the whole project. But when, at a recent count, I found
that in this general hospital of 130 beds we have no fewer than
90 patients suffering from tuberculosis. I realized that whether
we were disgusted or not, whether we wanted to do so or not,
we were compelled to reopen the campaign for the provision of
more accommodation, not only here but throughout the country.
And then-I happened to read the editorial in The TerrilOrial
News, Umtata of 20 September:
'The eighth annual meeting of delegates from the many branches
of SA ITA was held in Port Elizabeth last week. Since its incep-
tion, this splendid body has gone steadily forward in its aim to
halt the spread of the dread disease which, it was at one time
feared, would play such havoc with the Union's indigenous
population that their future would be gravely imperilled. Thanks
to scientific discoveries in recent years, and to a more vivid realiza-
tion of the danger ahead, hope has been aroused that, within a
measured term of years, tuberculosis can be overcome, provided
the public generally remains conscious of the danger, and is
prepared to assist in its eradication. The first and most important
steps necessary to fight the spread of the di ease is the segregation
of the sufferer in a manner which will prevent its communication
to others.
'The heavy cost of building hospitals makes it impracticable
to provide hospital beds for all those requiring treatment, and it
is in this direction that SA TA has come to the aid of South
Africa. Instead of £1,500 required for each hospital bed, SA TA
has found the way to provide beds at an average cost of a little
